Literature DB >> 2240112

Pregnancy outcomes among mothers infected with human immunodeficiency virus and uninfected control subjects.

H L Minkoff1, C Henderson, H Mendez, M H Gail, S Holman, A Willoughby, J J Goedett, A Rubinstein, P Stratton, J H Walsh.   

Abstract

Between June 26, 1985, and Feb. 24, 1989, 101 seropositive pregnant women and 129 seronegative pregnant women from the same prenatal clinics in Brooklyn and the Bronx were recruited into a prospective study of human immunodeficiency virus infection in pregnant women and their offspring. This report details the course of pregnancy and short-term neonatal outcomes of 91 seropositive women and 126 seronegative women who gave birth during the study period. Seropositive mothers were significantly more likely to have sexually transmitted diseases (17.6% vs 7.1%, p = 0.017) and medical complications (43.0% vs 25%, p = 0.006) during pregnancy. No other obstetric complications (e. g., chorioamnionitis, endometritis, toxemia, or placental problems) were associated with serologic status. After controlling for confounding variables (drug use, tobacco use, age of mother, and clinic), we found that the mother's serologic status was not significantly associated with birth weight, gestational age, head circumference, or Apgar scores among live infants. For example, after adjustment on confounders we found that children born to seropositive mothers weighed about 7 gm more than children of seronegative mothers (95% confidence interval, -180 to 194 gm). We conclude that in this population human immunodeficiency virus infection has little demonstrable impact on the status at birth of live neonates.

Entities:  

Mesh:

Year:  1990        PMID: 2240112

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

1.  Health care utilization among drug-using and non-drug-using women.

Authors:  Claire E Sterk; Katherine P Theall; Kirk W Elifson
Journal:  J Urban Health       Date:  2002-12       Impact factor: 3.671

2.  Maternal HIV and drug use: effect on health and social morbidity.

Authors:  J Y Mok; A Ross; G Raab; B Hamilton; S Gilkison; F D Johnstone
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

Review 3.  Perinatal transmission of HIV and diagnosis of HIV infection in infants: a review.

Authors:  C B Nourse; K M Butler
Journal:  Ir J Med Sci       Date:  1998 Jan-Mar       Impact factor: 1.568

4.  The association between maternal HIV-1 infection and pregnancy outcomes in Dar es Salaam, Tanzania.

Authors:  J L Coley; G I Msamanga; M C Fawzi; S Kaaya; E Hertzmark; S Kapiga; D Spiegelman; D Hunter; W W Fawzi
Journal:  BJOG       Date:  2001-11       Impact factor: 6.531

5.  Human chorionic gonadotropin hormone prevents wasting syndrome and death in HIV-1 transgenic mice.

Authors:  S K De; C R Wohlenberg; N J Marinos; D Doodnauth; J L Bryant; A L Notkins
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

Review 6.  Prenatal diagnosis and significance of fetal infections.

Authors:  A Ghidini; L Lynch
Journal:  West J Med       Date:  1993-09

Review 7.  Care of HIV-positive obstetric patients. Meeting a multigenerational challenge.

Authors:  C M Peckan
Journal:  Can Fam Physician       Date:  1994-08       Impact factor: 3.275

8.  Mother-to-child transmission of human immunodeficiency virus (HIV) in Ireland: a prospective study.

Authors:  C B Nourse; T Conlon; E Hayes; G Kaminski; E Griffin; I Hillary; K M Butler
Journal:  Ir J Med Sci       Date:  1998 Jul-Sep       Impact factor: 1.568

9.  Maternal-infant HIV transmission and circumstances of delivery.

Authors:  L Kuhn; Z A Stein; P A Thomas; T Singh; W Y Tsai
Journal:  Am J Public Health       Date:  1994-07       Impact factor: 9.308

Review 10.  The contribution of HIV to pregnancy-related mortality: a systematic review and meta-analysis.

Authors:  Clara Calvert; Carine Ronsmans
Journal:  AIDS       Date:  2013-06-19       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.